» Articles » PMID: 19243896

CD24 Expression Has a Prognostic Impact in Breast Carcinoma

Overview
Specialty Pathology
Date 2009 Feb 27
PMID 19243896
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the prognostic significance of BAG-1 and CD24 in invasive breast carcinomas. Seventy cases of invasive breast carcinoma were studied immunocytochemically for the expression of BAG-1 and CD24. The results were correlated with several prognostic parameters, including 5-year survival. Univariate analysis showed a significant correlation of BAG-1 and CD24 overall positive staining with several adverse prognostic parameters, such as increased stage (p<0.0001), tumor grade 3 (p=0.016 and p=0.02, respectively), positive lymph nodes (p<0.0001), and increased tumor size (p<0.0001). Similar results were found for BAG-1 nuclear staining, as well as for positive cytoplasmic CD24 expression. Both of our markers studied had a significant, negative effect on survival. Multivariate analysis further revealed an independent prognostic impact for CD24 overall staining. The results of our study showed that overall cytoplasmic and especially nuclear BAG-1 expression, as well as overall and cytoplasmic CD24 expression, correlates with adverse prognostic parameters. An independent prognostic value for overall CD24 staining was also demonstrated.

Citing Articles

Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?.

Du R, Zhang J, Lukas R, Tripathi S, Ahrendsen J, Curran M Neuro Oncol. 2024; 27(1):33-49.

PMID: 39427326 PMC: 11726257. DOI: 10.1093/neuonc/noae193.


From mechanism to therapy: the journey of CD24 in cancer.

Zhao K, Wu C, Li X, Niu M, Wu D, Cui X Front Immunol. 2024; 15:1401528.

PMID: 38881902 PMC: 11176514. DOI: 10.3389/fimmu.2024.1401528.


Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.

Moon S, Han M, Ryu G, Shin S, Lee J, Lee C Int J Mol Sci. 2023; 24(20).

PMID: 37894750 PMC: 10606340. DOI: 10.3390/ijms242015072.


Epithelial Ovarian Cancer and Cancer Stem Cells.

Soliman A, Elzarkaa A, Malik E Adv Exp Med Biol. 2021; 1330:21-32.

PMID: 34339028 DOI: 10.1007/978-3-030-73359-9_2.


Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma.

Choi K, Kim A, Kim J, Kim K, Hwang C, Lee S J Ovarian Res. 2020; 13(1):65.

PMID: 32513298 PMC: 7278194. DOI: 10.1186/s13048-020-00667-y.